Aegis Medical Systems - Hesperia

Headquartered in Los Angeles, and with 25 clinics in 15 counties throughout the state of California, Aegis Medical Systems, Inc. delivers an expansive set of services to more than 5,000 patients a day.

Over the last decade, Aegis has pursued a proactive agenda for the advancement of clinical standards and improved patient success rates. Such efforts required the provision of a holistic approach to patient care, with a multidisciplinary and integrated scope of treatment and services.


Aegis clinics are licensed and regulated by the Federal Drug Enforcement Agency (DEA), the Substance Abuse and Mental Health Services Administration (SAMHSA) of the US Department of Health and Human Services (DHHS), and the California Department of Alcohol & Drug Programs (CADP). Furthermore, Aegis Clinics are Medi-Cal and Medicare certified. All clinics also hold the highest level of accreditation granted by the Commission on Accreditation of Rehabilitation Facilities (CARF). Aegis is also recognized by the California Board of Behavioral Science (BBS), and Breining Institute, as an authorized provider of continuing education units (CEU's).

Aegis Medical Systems
11959 Mariposa Rd
Hesperia CA 92345
Tel: 760 956-2462
Fax: 760 956-7542

* Aegis’ goal is to support the successful recovery of its patients and improve the quality of their lives.
* Aegis is committed to providing evidence-based comprehensive treatment services incorporating multidisciplinary modalities.
* Aegis promotes the highest standard of patient care in the treatment of substance abuse and related medical, psychological and socio-economic conditions.
* Aegis and its staff members pursue excellence, integrity & commitment in the provision of effective patient care.


Aegis Medical Systems, Inc., ("Aegis") operates one of the largest networks of Narcotic Treatment Programs (NTPs), also known as Opiate Treatment Programs (OTPs), in the Nation. In 1998, Aegis began implementation of a business plan that would upgrade the network into a "State of the Art" continuum of care, a model that has set the standard for OTP operations throughout the country.

The Aegis business plan was instrumental in repositioning the organization into mainstream medical care. Aegis meets and exceeds the most stringent of operating and medical standards in its practice of health care. Aegis employs the most advanced policies, protocols and procedures known to the industry, and is involved with cutting-edge pharmaceutical and behavioral research & development projects with some of the most prominent research institutions (i.e., UCLA, the RAND Corporation),pharmaceutical companies (i.e., Bayer, Johnson & Johnson, etc.) and government agencies (i.e., NIDA, NIH, NIAAA, CDC).

Aegis provides a comprehensive treatment modality, allowing various staff members to address and sustain the diverse needs of its patients. Along with addiction treatment through "replacement therapy," Aegis has implemented additional protocols and procedures for the treatment of co-occurring mental, emotional and behavioral conditions, including Post Traumatic Stress Disorder (PTSD), Attention Deficit Disorders (ADD/ADHD), Grief & Loss, Stress & Anxiety, Anger and other personality disorders, etc. In addition, Aegis also provides counseling, case management, social work, referrals to community resources, educational programs, eligibility work, vocational rehabilitation and nutritional counseling.

To meet its staffing needs, Aegis has developed training and internship programs in collaboration with over 35 leading academic institutions throughout California, including: UCLA; USC; Cal State LA, Chico, Fresno, and Bakersfield; Cal Poly San Luis Obispo, and Pomona; UC Davis; UCSB; Pepperdine University; Loma Linda University.

Aegis also collaborates with governmental regulatory agencies. These agencies include the Federal Drug Enforcement Administration (DEA), the Substance Abuse and Mental Health Services Administration / Center of Substance Abuse Treatment (SAMHSA/CSAT), the Commission on Accreditation of Rehabilitation Facilities (CARF), and the Food and Drug Administration (FDA), as well as the California Department of Alcohol and Drug Programs (CADP), and the County offices of Alcohol and Drug Programs.
Comments: 0